glucose tetrasaccharide

Subscribe to Selected New Research on glucose tetrasaccharide

10 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: urinary tetrasaccharide

Also Known As:

(Glc)4; Glc alpha 1-6 Glc alpha 1-4 Glc alpha 1-4 Glc; D-Glucose, O-alpha-D-glucopyranosyl- (1-6)-O-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-

Bio-Agent Context: Research Results

Carbohydrates: 2946

Polysaccharides: 1645

Oligosaccharides: 1105

glucose tetrasaccharide: 10

Experts

1.	An, Yan: 2 articles (08/2005 - 05/2003)
2.	Young, Sarah P: 2 articles (08/2005 - 05/2003)
3.	Millington, David S: 2 articles (08/2005 - 05/2003)
4.	Chen, Yuan-Tsong: 2 articles (08/2005 - 05/2003)
5.	Amalfitano, Andrea: 1 article (08/2005)
6.	Kishnani, Priya S: 1 article (08/2005)
7.	Corz, Deyanira: 1 article (08/2005)
8.	Stevens, Robert D: 1 article (05/2003)
9.	Van Hove, J L: 1 article (12/2000)
10.	An, Y: 1 article (12/2000)

Related Diseases

1.	Carcinoma (Carcinomatosis) 02/17/2003 - "Doxorubicin exposure reversibly inactivated IRP1 in small cell lung carcinoma (GLC(4)) and myelogenous leukemia (K562) cell lines, but was without effect in their derived doxorubicin-resistant sublines" 05/01/2003 - "The aim of this study was to investigate the effect of adriamycin (ADR) in signaling activation of NF-kappaB in ADR-sensitive and -resistant GLC(4) human small-cell lung carcinoma" Get all the results and reference details, order at left...
2.	Small Cell Carcinoma (Small Cell Lung Cancer) 09/01/2000 - "The toxicity of 4HNE was tested with the small cell lung cancer cell lines GLC(4) and the multidrug-resistance-protein (MRP1)-overexpressing counterpart GLC(4)/Adr" 05/15/2002 - "The human U-1285 and GLC(4) cell lines, both derived from small cell carcinoma of the lung, are present in doxorubicin-sensitive (U-1285 and GLC(4)) and doxorubicin-resistant MRP-expressing (U-1285dox and GLC(4)/ADR) variants" 03/01/2001 - "Ultrastructural morphology (transmission electron microscopy) and localisation of cisplatin-induced platinum (Pt)-DNA adducts (immunoelectron microscopy) were analysed in the human small cell lung cancer cell line GLC(4) and its 40-fold in vitro acquired cisplatin-resistant subline GLC(4)-CDDP, which is characterised by, among other things, a decreased DNA platination" Get all the results and reference details, order at left...
3.	Glycogen Storage Disease Type II (Pompe's Disease) 08/01/2005 - "Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease." 12/01/2000 - "Concentrations of Glc(4) in both urine and plasma were established for the age ranges of <1, 1-5, 6-10, 11-20, and >20 years, both in normal individuals and in a cohort of 21 patients with enzymatically confirmed Pompe disease" 12/01/2000 - "Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease." 05/15/2003 - "Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry." 05/15/2003 - "Patients with glycogen storage disease type II (GSD II) typically excrete increased amounts of a glycogen-derived glucose tetrasaccharide, Glcalpha1-6Glcalpha1-4Glcalpha1-4Glc (Glc(4)), in the urine" Get all the results and reference details, order at left...
4.	Pancreatitis 10/01/1989 - "Analysis of both serum and urine samples from normal individuals and patients with acute pancreatitis gives a single retarded peak with a retention time identical to that of authentic (Glc)4. Retarded material pooled from several analyses of urine was positively identified as (Glc)4 by GC-MS analysis" Get all the results and reference details, order at left...
5.	Myeloid Leukemia (Leukemia, Myelocytic) 02/17/2003 - "Doxorubicin exposure reversibly inactivated IRP1 in small cell lung carcinoma (GLC(4)) and myelogenous leukemia (K562) cell lines, but was without effect in their derived doxorubicin-resistant sublines" Get all the results and reference details, order at left...
6 Diseases and 10 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)
2.	NF-kappa B (NF-kB)
3.	Glycogen
4.	glucose tetrasaccharide
5.	DNA Adducts
6.	Platinum
7.	Glucose (Dextrose)
8.	DNA (Deoxyribonucleic Acid)
9.	Cisplatin (Platino)
10.	TANDEM
10 Drugs and Important Bio-Agents and 6 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>